Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 5, 2003, Pages 391-400

  Corpet, Denis E ^a   Pierre, Fabrice ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZOXYMETHANE; CAFFEIC ACID; CATECHIN; CELECOXIB; CURCUMIN; EFLORNITHINE; EKI 785; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; FISH OIL; FLURBIPROFEN; FOLIC ACID; HESPERIDIN; JTE 523; MACROGOL; MACROGOL 3350; MACROGOL 8000; NONSTEROID ANTIINFLAMMATORY AGENT; PELITINIB; PIROXICAM; PROTEINASE INHIBITOR; RESVERATROL; RO 269114; ROFECOXIB; ROSIGLITAZONE; SC 26196; SPHINGOMYELIN; SULFONIC ACID DERIVATIVE; SULINDAC; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; UROGUANYLIN; VITAMIN D;

ANIMAL MODEL; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLON CANCER; COLON POLYP; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; EXERCISE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; CHEMOPREVENTION; COLONIC NEOPLASMS; DIET; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, MUTANT STRAINS; PRECANCEROUS CONDITIONS; RANDOMIZED CONTROLLED TRIALS; RATS;

EID: 0038075469     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Jacoby, R. F., Cole, C. E., Lubet, R. A., and You, M. Effect of the nonspecific Cox1/2 inhibitor piroxicam and the ormithine decarboxylase inhibitor difluoromethylomitine (DFMO) on development of intestinal tumors in mice bearing germline alteration the Msh2 or APC genes. Proc. Am. Assoc. Cancer Res., 42: 263, #1422, 2001.
2. Yang, K., Fan, K., Shinozaki, H., Newmark, H., Edelmann, W., Kucherlapati, R., and Lipkin, M. Sulindac increases carcinoma development in the colons of mice with Apc mutations. Proc. Am. Assoc. Cancer Res., 40: 523, #3488, 1999.
3. Yang, K., Fan, K., Lia, M., Edelmann, W., Augenlicht, L. H., Lubet, R., Kopelovich, L., Kucherlapati, R., and Lipkin, M. Sulindac increases tumor development in the colon of mice with Mlh1 +/-mutation. Proc. Am. Assoc. Cancer Res., 42: 264, #1423, 2001. Proc. Am. Assoc. Cancer Res.
4. Thun, M. J., Henley, J., and Patrono, C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst., 94: 252-266, 2002.
5. Dashwood, R. H., Suzui, M., Nakagama, H., Sugimura, T., and Nagao, M. High frequency of β-catenin (Ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res., 58: 1127-1129, 1998.
6. DeFilippo, C., Caderni, G., Bazzicalupo, M., Briani, C., Giannini, A., Fazi, M., and Dolara, P. Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats. Br. J. Cancer, 77: 2148-2151, 1998.
7. Corpet, D. E., and Tache, S. Most effective colon cancer chemopreventive agents in rats: a review of aberrant crypt foci and tumor data, ranked by potency. Nutr. Cancer, 43: 1-21, 2002.
8. Kakiuchi, H., Watanabe, M., Ushijima, T., Toyota, M., Imai, K., Weisburger, J. H., Sugimura, T., and Nagao, M. Specific 5′-GGGA-3′ to 5′-GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine. Proc. Natl. Acad. Sci. USA, 92: 910-914, 1995.
9. Canzian, F., Ushijima, T., Serikawa, T., Wakabayashi, K., Sugimura, T., and Nagao, M. Instability of microsatellites in rat colon tumors induced by heterocyclic amines. Cancer Res., 54: 6315-6317, 1994.
10. Kakiuchi, H., Ushijima, T., Ochiai, M., Imai, K., Ito, N., Yachi, A., Sugimura, T., and Nagao, M. Rare frequency of activation of the ki-ras gene in rat colon tumors induced by heterocyclic amines - possible alternative mechanisms of human colon carcinogenesis. Mol. Carcinog., 8: 44-48, 1993.
11. Makino, H., Ushijima, T., Kakiuchi, H., Onda, M., Ito, N., Sugimura, T., and Nagao, M. Absence of p53 mutations in rat colon tumors induced by 2-amino-6-methyldipyrido[l, 2-a:3′, 2′-d]imidazole, 2-amino-3-methylimid azo[4, 5-f]quinoline, or 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Jap. J. Cancer Res., 85: 510-514, 1994.
12. Moser, A. R., Pitot, H. C., and Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science (Wash. DC), 247: 322-324, 1990.
13. Shoemaker, A. R., Luongo, C., Moser, A. R., Marton, L. J., and Dove, W. F. Somatic mutational mechanisms involved in intestinal tumor formation in Min mice. Cancer Res., 57: 1999-2006, 1997.
14. Fazeli, A., Steen, R. G., Dickinson, S. L., Bautista, D., Dietrich, W. F., Bronson, R. T., Bresalier, R. S., Lander, E. S., Costa, J., and Weinberg, R. A. Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. Proc. Natl. Acad. Sci. USA, 94: 10199-10204, 1997.
15. DeWind, N., Dekker, M., VanRossum, A., VanderValk, M., and Riele, H. T. Mouse models for hereditary nonpolyposis colorectal cancer. Cancer Res., 58: 248-255, 1998.
16. Mahmoud, N. N., Dannenberg, A. J., Bilinski, R. T., Mestre, J. R., Chadburn, A., Churchill, M., Martucci, C., and Bertagnolli, M. M. Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis. Carcinogenesis (Lond.), 20: 299-303, 1999.
17. Jacoby, R. F., Cole, C. E., Hawk, E. T., and Lubet, R. A. Urodeoxycholate plus low dose sulindac is an effective chemopreventive agent combination that is well tolerated and decreases adenoma multiplicity in the Apc mutant Min mouse. Proc. Am. Assoc. Cancer Res., 43: 3322, 2002.
18. HansenPetrik, M. B., McEntee, M. F., Johnson, B. T., Obukowicz, G., Masferrer, J., Zweifel, B., Chiu, C. H., and Whelan, J. Selective inhibition of δ-6 desaturase impedes intestinal tumorigenesis. Cancer Lett., 175: 157-163, 2002.
19. Wasan, H. S., Novelli, M., Bee, J., and Bodmer, W. F. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc. Natl. Acad. Sci. USA, 94: 3308-3313, 1997.
20. Oshima, M., Takahashi, M., Oshima, H., Tsutsumi, M., Yazawa, K., Sugimura, T., Nishimura, S., Wakabayashi, K., and Taketo, M. M. Effects of docosahexaenoic acid (DHA) on intestinal polyp development in apc(δ716) knockout mice. Carcinogenesis (Lond.), 16: 2605-2607, 1995.
21. Paulsen, J. E., Elvsaas, I. K. O., Steffensen, I. L., and Alexander, J. A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse. Carcinogenesis (Lond.), 18: 1905-1910, 1997.
22. Mutanen, M., Pajari, A. M., and Oikarinen, S. I. Beef induces and rye bran prevents the formation of intestinal polyps in apc(min) mice: relation to β-catenin and PKC isozymes. Carcinogenesis (Lond.), 21: 1167-1173, 2000.
23. Yu, C. F., Whiteley, L., Carryl, O., and Basson, M. D. Differential dietary effects on colonic and small bowel neoplasia in C57BL/6j Apc Min/+ mice. Dig. Dis. Sci., 46: 1367-1380, 2001.
24. Yang, K., Edelmann, W., Fan, K. H., Lau, K., Leung, D., Newmark, H., Kucherlapati, R., and Lipkin, M. Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis. Cancer Res., 58: 5713-5717, 1998.
25. Pierre, F., Perrin, P., Champ, M., Bornet, F., Meflah, K., and Menanteau, J. Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. Cancer Res., 57: 225-228, 1997.
26. Pierre, F., Perrin, P., Bassonga, E., Bornet, F., Meflah, K., and Menanteau, J. T cell status influences colon tumor occurrence in Min mice fed short chain fructo-oligosaccharides as a diet supplement. Carcinogenesis (Lond.), 20: 1953-1956, 1999.
27. Pajari, A. M., Rajakangas, J., Paivarinta, E., Kosam, V. M., Rafter, J., and Mutanen, M. Inulin modulates intestinal tumor formation partly through an accumulation of cytosolic B-catenin in Min mice. AACR special conference in Cancer Res. Colon cancer: genetics to prevention. Philadelphia, Pennsylvania, March 7-10, 2002. A-16, 2002.
28. Oikarinen, S. I., Pajari, A. M., and Mutanen, M. Chemopreventative activity of crude hydroxsymatairesinol (HMR) extract in adenomatous polyposis coli multiple intestinal neoplasia (APC, min) mice. Cancer Lett., 161: 253-258, 2000.
29. Hioki, K., Shivapurkar, N., Oshima, H., Alabaster, O., Oshima, M., and Taketo, M. M. Suppression of intestinal polyp development by low-fat and high-fiber diet in Apc (δ 716) knockout mice. Carcinogenesis (Lond.), 18: 1863-1865, 1997.
30. Oshima, M., Oshima, H., Tsutsumi, M., Nishimura, S., Sugimura, T., Nagao, M., and Taketo, M. M. Effects of 2-amino-1-methyl-6-phenylimidazo[4, 5b]pyridine on intestinal polyp development in apc(δ 716) knockout mice. Mol. Carcinog., 15: 11-17, 1996.
31. Andreassen, A., Vikse, R., Steffensen, I. L., Paulsen, J. E., and Alexander, J. Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phelylimidazo[4, 5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc+ allele. Mutagenesis, 16: 309-315, 2001.
32. Steffensen, I. L., Schut, H. A. J., Paulsen, J. E., Andreassen, A., and Alexander, J. Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts. Cancer Res., 61: 8689-8696, 2001.
33. Steffensen, I. L., Paulsen, J. E., Eide, T. J., and Alexander, J. 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice. Carcinogenesis (Lond.), 18: 1049-1054, 1997.
34. Sorensen, I. K., Kristiansen, E., Mortensen, A., Vankranen, H., Vankreijl, C., Fodde, R., and Thorgeirsson, S. S. Short-term carcinogenicity testing of a potent murine intestinal mutagen, 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine (phIP), in apc1638n transgenic mice. Carcinogenesis (Lond.), 18: 777-781, 1997.
35. Torrance, C. J., Jackson, P. E., Montgomery, E., Kinzler, K. W., Vogelstein, B., Wissner, A., Nunes, M., Frost, P., and Discafani, C. M. Combinatorial chemoprevention of intestinal neoplasia. Nat. Med., 6: 1024-1028, 2000.
36. Ahn, B., and Ohshima, H. Suppression of intestinal polyposis in Apc (Min/+) mice by inhibiting nitric oxide production. Cancer Res., 61: 8357-8360, 2001.
37. Erdman, S. H., Ignatenko, N. A., Powell, M. B., Blohmmangone, K. A., Holubec, H., Guillenrodriguez, J. M., and Gerner, E. W. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse. Carcinogenesis (Lond.), 20: 1709-1713, 1999.
38. Jacoby, R. F., Cole, C. E., Tutsch, K., Newton, M. A., Kelloff, G., Hawk, E. T., and Lubet, R. A. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res., 60: 1864-1870, 2000.
39. Ritland, S. R., Leighton, J. A., Hirsch, R. E., Morrow, J. D., Weaver, A. L., and Gendler, S. J. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc Min mouse. Clin. Cancer Res., 5: 855-863, 1999.
40. MacGregor, D. J., Kim, Y. S., Sleisenger, M. H., and Johnson, L. K. Chemoprevention of colon cancer carcinogenesis by balsalazide: Inhibition of azoxymethane-induced aberrant crypt formation in the rat colon and intestinal tumor formation in the B6-Min/+ mouse. Int. J. Oncol., 17: 173-179, 2000.
41. Barnes, C. J., and Lee, M. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin. Gastroenterology, 114: 873-877, 1998.
42. Sansom, O. J., Stark, L. A., Dunlop, M. G., and Clarke, A. R. Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc-(min/+) and Apc(min/+). Msh2(-/-) mice. Cancer Res., 61: 7060-7064, 2001.
43. Jacoby, R. F., Marshall, D. J., Newton, M. A., Novakovic, K., Tutsch, K., Cole, C. E., Lubet, R. A., Kelloff, G. J., Verma, A., Moser, A. R., and Dove, W. F. Chemoprevention of spontaneous intestinal adenomas in the apc (min) mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res., 56: 710-714, 1996.
44. Jacoby, R. F., Seibert, K., Cole, C. E., Kelloff, G., and Lubet, R. A. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the Min mouse model of adenomatous polyposis. Cancer Res., 60: 5040-5044, 2000.
45. Ritland, S. R., and Gendler, S. J. Chemoprevention of intestinal adenomas in the apc(min) mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression. Carcinogenesis (Lond.), 20: 51-58, 1999.
46. Quesada, C. F., Kimata, H., Mori, M., Nishimura, M., Tsuneyoshi, T., and Baba, S. Piroxicam and acarbose as chemopreventive agents for spontaneous intestinal adenomas in APC gene 1309 knockout mice. Jpn. J. Cancer Res., 89: 392-396, 1998.
47. Wechter, W. J., Murray, D. E. D., Kantoci, D., Quiggle, D. D., Leipold, D. D., Gibson, K. M., and McCracken, J. D. Treatment and survival study in the C57bl/6J-Apc Min mouse with R-flurbiprofen. Life Sci., 66: 745-753, 2000.
48. Boolbol, S. K., Dannenberg, A. J., Chadburn, A., Martucci, C., Guo, X. J., Ramonetti, J. T., Abreugoris, M., Newmark, H. L., Lipkin, M. L., Decosse, J. J., and Bertagnolli, M. M. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56: 2556-2560, 1996.
49. Chiu, C. H., Mcentee, M. F., and Whelan, J. Sulindac causes rapid regression of preexisting tumors in min/+ mice independent of prostaglandin biosynthesis. Cancer Res., 57: 4267-4273, 1997.
50. Huerta, S., Irwin, R. W., Heber, D., Go, V. L. W., Koeffler, H. P., Uskokovic, M. R., and Harris, D. M. 1 α, 25-(OH)(2)-d-3 and its synthetic analogue decrease tumor load in the apc(min) mouse. Cancer Res., 62: 741-746, 2002.
51. Suganuma, M., Ohkura, Y., Okabe, S., and Fujiki, H. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J. Cancer Res. Clin. Oncol., 127: 69-72, 2001.
52. Oshima, M., Murai, N., Kargman, S., Arguello, M., Luk, P., Kwong, E., Taketo, M. M., and Evans, J. F. Chemoprevention of intestinal polyposis in the apc(δ 716) mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res., 61: 1733-1740, 2001.
53. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M. Suppression of intestinal polyposis in apc(δ 716) knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
54. Lal, G., Ash, C., Hay, K., Redston, M., Kwong, E., Hancock, B., Mak, T., Kargman, S., Evans, J. F., and Gallinger, S. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Cancer Res., 61: 6131-6136, 2001.
55. Sasai, H., Masaki, M., and Wakitani, K. Suppression of polypogenesis in a new mouse strain with a truncated apc(δ 474) by a novel COX-2 inhibitor. JTE-522. Carcinogenesis (Lond.), 21: 953-958, 2000.
56. Mutoh, M., Watanabe, K., Kitamura, T., Shoji, Y., Takahashi, M., Kawamori, T., Tani, K., Kobayashi, M., Maruyama, T., Kobayashi, K., Ohuchida, S., Sugimoto, Y., Narumiya, S., Sugimura, T., and Wakabayashi, K. Involvement of prostaglandin E receptor subtype EP4 in colon carcinogenesis. Cancer Res., 62: 28-32, 2002.
57. Ushida, Y., Sekine, K., Kuhara, T., Takasuka, N., Iigo, M., and Tsuda, H. Inhibitory effects of bovine lactoferrin on intestinal polyposis in the Apc Min mouse. Cancer Let., 134: 141-145, 1998.
58. Newman, J. V., Kosaka, T., Sheppard, B. J., Fox, J. G., and Schauer, D. B. Bacterial infection promotes colon tumorigenesis in apc(min/+) mice. J. Infect. Dis., 184: 227-230, 2001.
59. Davis, C. D., and Newman, S. Inadequate dietary copper increases tumorigenesis in the Min mouse. Cancer Lett., 159: 57-62, 2000.
60. Cooper, H. S., Everley, L., Chang, W. C., Pfeiffer, G., Lee, B., Murthy, S., and Clapper, M. L. The role of mutant apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis. Gastroenterology, 121: 1407-1416, 2001.
61. Colbert, L. H., Davis, J. M., Essig, D. A., Ghaffar, A., and Mayer, E. P. Exercise and tumor development in a mouse predisposed to multiple intestinal adenomas. Med. Sci. Sports Exerc., 32: 1704-1708, 2000.
62. Kakuni, M., Morimura, K., Wanibuchi, H., Ogawa, M., Min, W., Hayashi, S., and Fukushima, S. Food restriction inhibits the growth of intestinal polyps in multiple intestinal neoplasia mouse. Jpn. J. Cancer Res., 93: 236-241, 2002.
63. Dove, W. F., Clipson, L., Gould, K. A., Luongo, C., Marshall, D. J., Moser, A. R., Newton, M. A., and Jacoby, R. F. Intestinal neoplasia in the APC Min mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res., 57: 812-814, 1997.
64. Paulsen, J. E., and Alexander, J. Growth stimulation of intestinal tumours in apc(min/+) mice by dietary 1-methionine supplementation. Anticancer Res., 21: 3281-3284, 2001.
65. Ansari, S. H., DiBaise, J., Gulizia, J., Karolski, W. J., Ratashak, A., Wali, R. K., and Roy, H. K. Polyethylene glycol 3350 suppresses intestinal tumorigenesis in the Min mouse. Gastroenterology, 122: A-215 #S1367, 2002.
66. Naigamwalla, D., Chia, M. C., Tran, T. T., Medline, A., Hay, K., Gallinger, S., and Bruce, W. R. Polyethylene glycol 8000 and colon carcinogenesis: inhibition in the F344 rat, promotion in the Min mouse. Cancer Res., 60: 6856-6858, 2000.
67. Davis, C. D., Zeng, H. W., and Finley, J. W. Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J. Nutr., 132: 307-309, 2002.
68. Rao, C. V., Cooma, I., Rodriguez, J. G. R., Simi, B., Elbayoumy, K., and Reddy, B. S. Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1, 4-phenylene bis (methylene)selenocyanate. Carcinogenesis (Lond.), 21: 617-621, 2000.
69. Schmelz, E. M., Roberts, P. C., Kustin, E. M., Lemonnier, L. A., Sullards, M. C., Dillehay, D. L., and Merrill, A. H. Modulation of intracellular β-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Cancer Res., 61: 6723-6729, 2001.
70. Shailubhai, K., Yu, H. H., Karunanandaa, K., Wang, J. Y., Eber, S. L., Wang, Y., Joo, N. S., Kim, H. D., Miedema, B. W., Abbas, S. Z., Boddupalli, S. S., Currie, M. G., and Forte, L. R. Uroguanylin treatment suppresses polyp formation in the Apc Min/+ mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res., 60: 5151-5157, 2000.
71. VarKranen, H. J., Vaniersel, P. W. C., Rijnkels, J. M., Beems, D. B., Alink, G. M., and Vankreijl, C. F. Effects of dietary fat and a vegetable-fruit mixture on the development of intestinal neoplasia in the apc(min) mouse. Carcinogenesis (Lond.), 19: 1597-1601, 1998.
72. Kennedy, A. R., BeazerBarclay, Y., Kinzler, K. W., and Newberne, P. M. Suppression of carcinogenesis in the intestines of Min mice by soybean-derived Bowman-Birk inhibitor. Cancer Res., 56: 679-682, 1996.
73. Mahmoud, N. N., Carothers, A. M., Grunberger, D., Bilinski, R. T., Churchill, M. R., Martucci, C., Newmark, H. L., and Bertagnolli, M. M. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis (Lond.), 21: 921-927, 2000.
74. Weyant, M. J., Carothers, A. M., Dannenberg, A. J., and Bertagnolli, M. M. (+)-catechin inhibits intestinal tumor formation and suppresses focal adhesion kinase activation in the min/+ mouse. Cancer Res., 61: 118-125, 2001.
75. Collett, G. P., Robson, C. N., Mathers, J. C., and Campbell, F. C. Curcumin modifies apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4, 5-b]pyridine (phIP) induced turnout formation in apc(min) mice. Carcinogenesis (Lond.), 22: 821-825, 2001.
76. Schneider, Y., Duranton, B., Gosse, F., Schleiffer, R., Seiler, N., and Raul, F. Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr. Cancer, 39: 102-107, 2001.
77. Sorensen, I. K., Kristiansen, E., Mortensen, A., Nicolaisen, G. M., Wijnandes, J. A. H., Vankranen, H. J., and Vankreijl, C. F. The effect of soy isoflavones on the development of intestinal neoplasia in Apc (min) mouse. Cancer Lett., 130: 217-225, 1998.
78. Lefebvre, A. M., Chen, I. H., Desreumaux, P., Najib, J., Fruchart, J. C., Geboes, K., Briggs, M., Heyman, R., and Auwerx, J. Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in c57BL/6j-APC(min)/+ mice. Nat. Med., 4: 1053-1057, 1998.
79. Saez, E., Tontonoz, P., Nelson, M. C., Alvarez, J. G. A., TMU, Baird, S. M., Thomazy, V. A., and Evans, R. M. Activators of the nuclear receptor PPAR γ enhance colon polyp formation. Nat. Med., 4: 1058-1061, 1998.
80. Song, J., Medline, A., Mason, J. B., Gallinger, S., and Kim, Y. I. Effects of dietary folate on intestinal tumorigenesis in the apc(min) mouse. Cancer Res., 60: 5434-5440, 2000.
81. Song, J., Sohn, K. J., Medline, A., Ash, C., Gallinger, S., and Kim, Y. I. Chemopreventive effects of dietary folate on intestinal polyps in apc+/ -msh2-/- mice. Cancer Res., 60: 3191-3199, 2000.
82. Sibani, S., Melnyk, S., Pogribny, I. P., Wang, W., Hioutim, F., Deng, L. Y., Trasler, J., James, S. J., and Rozen, R. Studies of methionine cycle intermediates (SAM. SAH), DNA methylation and the impact of folate deficiency on tumor numbers in Min mice. Carcinogenesis (Lond.), 23: 61-65, 2002.
83. Fajas, L., Auboeuf, D., Raspe, E., Schoonjans, K., Lefebvre, A. M., Saladin, R., Najib, J., Laville, M., Fruchart, J. C., Deeb, S., VidalPuig, A., Flier, J., Briggs, M. R., Staels, B., Vidals, H., and Auwerx, J. The organization, promoter analysis, and expression of the human PPAR γ gene. J. Biol. Chem., 272: 18779-18789, 1997.
84. Li, H., Kramer, P. M., Lubet, R. A., Steele, V. E., Kelloff, G. J., and Pereira, M. A. Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in rats. Cancer Lett., 147: 187-193, 1999.
85. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B. S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55: 1464-1472, 1995.
86. Kawamori, T., Rao, C. V., Seibert, K., and Reddy, B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58: 409-412, 1998.
87. Rao, C. V., Tokumo, K., Rigotty, J., Zang, E., Kelloff, G., and Reddy, B. S. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, α-difluoromethylornithine, 16α-fluoro- 5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res., 51: 4528-4534, 1991.
88. Parnaud, G., Tache, S., Peiffer, G., and Corpet, D. E. Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats. Cancer Res., 59: 5143-5147, 1999.
89. Corpet, D. E., Parnaud, G., Delverdier, M., Peiffer, G., and Tache, S. Consistent and fast inhibition of colon carcinogenesis by polyethylene glycol in mice and rats given various carcinogens. Cancer Res., 60: 3160-3164, 2000.
90. Tischfield, J. A. A reassessment of the low molecular weight phopholipase A2 gene family in mammals. J. Biol. Chem., 272: 17247-17250, 1997.
91. Dimberg, J., Samuelson, A., Hugander, A., and Soderkvist, P. Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer. Anticancer Res., 18: 3283-3287, 1998.
92. Rao, C. V., Simi, B., Wynn, T. T., Gar, K., and Reddy, B. S. Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation furing different stages of colon tumor promotion in male F344 rats. Cancer Res., 56: 532-537, 1996.
93. Takaku, K., Sonoshita, M., Sasaki, N., Uozumi, N., Doi, Y., Shimizu, T., and Taketo, M. M. Suppression of intestinal polyposis in Apc(δ 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) gene. J. Biol. Chem., 275: 34013-34016, 2000.
94. Kawajiri, H., Hsi, L. C., Kamitani, H., Ikawa, H., Geller, M., Ward, T., Eling, T. E., and Glasgow, W. C. Arachidonic and linoleic acid metabolism in mouse intestinal tissue: evidence to novel lipoxygenase activity. Arch. Biochem. Biophys., 398: 51-60, 2002.
95. Clark, L. C., Dalkin, B., Krongrad, A., Combs, G. F., Jr. Turnbull, B. W., Slate, E. H., Witherington, R., Herlong, J. H., Janosko, E., Carpenter, D., Borosso, C., Falk, S., and Rounder, J. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br. J. Urol., 81: 730-734, 1998.
96. Steinbach, G., Lynch, P. M., Phillips, R. K., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L. K., and Levin, B. The effect of celecoxib, a cyclooxydenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med., 342: 1946-1952, 2000.
97. Baron, J. A., Cole, B. F., Mott, L. A., for the Polyp Prevention Study Group. Aspirin chemoprevention of colorectal cancer. Proc. Am. Assoc. Cancer Res., 43: 3319, 2002.
98. Giardiello, F. M., Yang, V. W., Hylind, L. M., Krush, A. J., Petersen, G. M., Trimbath, J. D., Piantadosi, S., Garrett, E., Hubbard, W., Geiman, D. E., Hubbard, W., Offerhaus, G. J., and Hamilton, S. R. Primary chemoprevention of familial adenomatous polyposis with sulindac. N. Engl. J. Med., 346: 1054-1059, 2002.
99. Baron, J. A., Beach, M., Mandel, J. S., Vanstolk, R. U., Haile, R. W., Sandler, R. S., Rothstein, R., Summers, R. W., Snover, D. C., Beck, G. J., Bond, J. H., and Greenberg, E. R. Calcium supplements for the prevention of colorectal adenomas. N. Engl. J. Med., 340: 101-107, 1999.
100. Alberts, D. S., Martinez, M. E., Roe, D. J., Guillenrodriguez, J. M., Marshall, J. R., Vanleeuwen, J. B., Reid, M. E., Ritenbaugh, C., Vargas, P. A., Bhattacharyya, A. B., Earnest, D. L., Sampliner, R. E., Parish, D., Koonce, K., and Fales, L. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N. Engl. J. Med., 342: 1156-1162, 2000.
101. Zhao, L. P., Kushi, L. H., Klein, R. D., and Prentice, R. L. Quantitative review of studies of dietary fat and rat colon carcinoma. Nutr. Cancer, 15: 169-177, 1991.
102. Schatzkin, A., Lanza, E., Corle, D., Lance, P., Iber, F., Caan, B., Shike, M., Weissfeld, J., Burt, R., Cooper, M. R., Kikendall, J. W., Cahill, J., Freedman, L., Marshall, J., Schoen, R. E., and Slattery, M. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N. Engl. J. Med., 342: 1149-1155. 2000.
103. McKeown-Eyssen, G. E., Bright-See, E., Bruce, W. R., Jazmaji, V., and Toronto-Polyp-Prevention-Group. A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps. J. Clin. Epidemiol., 47: 525-536, 1994.
104. MacLennan, R., Macrae, F., Bain, C., Battistutta, D., Chapuis, P., Gratten, H., Lambert, J., Newland, R. C., Ngu, M., Russell, A., Ward, M., and Wahlqvist, M. L. Randomized trial of intake of fat, fiber, and β carotene to prevent colorectal adenomas. J. Natl. Cancer Inst., 87: 1760-1766, 1995.
105. Alink, G. M., Kuiper, H. A., Hollanders, V. M. H., and Koeman, J. H. Effect of heat processing and of vegetables and fruit in human diets on 1, 2-dimethylhydrazine-induced colon carcinogenesis in rats. Carcinogenesis (Lond.), 14: 519-524, 1993.
106. Rijnkels, J. M., Hollanders, V. M. H., Woutersen, R. A., Koeman, J. H., and Alink, G. M. Absence of an inhibitory effect of a vegetables-fruit mixture on the initiation and promotion phases of azoxymethane-induced colorectal carcinogenesis in rats fed low- or high-fat diets. Nutr. Cancer, 30: 124-129, 1998.
107. Rijnkels, J. M., Hollanders, V. M. H., Woutersen, R. A., Koeman, J. H., and Alink, G. M. Interaction of dietary fat and of a vegetables/fruit mixture on 1, 2-dimethylhydrazine-induced colorectal cancer in rats. Nutr. Cancer, 27: 261-266, 1997.
108. Greenberg, E. R., Baron, J. A., Tosteson, T. D., Freeman, D. H., Beck, G. J., Bond, J. H., Colacchio, T. A., Coller, J. A., Frankl, H. D., Haile, R. W., Mandel, J. S., Nierenberg, D. W., Rothstein, R., Shover, D. C., Stevens, M. M., Summers, R. W., and Vanstolk, R. U. Clinical trial of antioxidant vitamins to prevent colorectal adenoma. N. Engl. J. Med., 331: 141-147, 1994.
109. Angres, G., and Beth, M. Effects of dietary constituents on carcinogenesis in different tumor models: an overview from 1975 to 1988. In: R. B. Alfin-Slater and D. Kritchevsky (eds.), Cancer and Nutrition, pp. 337-485. New York: Plenum Press, 1991.
110. McKeown-Eyssen, G., Holloway, C., Jazmaji, V., Bright-See, E., Dion, P., and Bruce, W. R. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res., 48: 4701-4705, 1988.
111. BonithonKopp, C., Kronborg, O., Giacosa, A., Rath, U., and Faivre, J. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. Lancet, 356: 1300-1306, 2000.
112. Giovannucci, E. The prevention of colorectal cancer by aspirin use. Biomed. Pharm., 53: 303-308, 1999.
113. Giovannucci, E. Insulin and colon cancer. Cancer Causes Control, 6: 164-179, 1995.
114. Willett, W. C. Polyunsaturated fat and the risk of cancer. Br. Med. J., 311: 1239-1240, 1995.
115. Lutz, W. K., and Schlatter, J. Chemical carcinogens and overnutrition in diet-related cancer. Carcinogenesis (Lond.), 13: 2211-2216, 1992.
116. Willett, W. C. Diet and cancer: one view at the start of the millenium. Cancer Epidemiol. Biomark. Prey., 10: 3-8, 2001.
117. McKeown-Eyssen, G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol. Biomark. Prey., 3: 687-695, 1994.
118. Gerber, M., BoutronRuault, M. C., Hercberg, S., Riboli, E., Scalbert, A., and Siess, M. H. Actualités en cancérologie: fruits, légumes er cancers. Une synthèse du réseau Nacre. Bull. Cancer (Paris), 89: 293-312, 2002.
119. World Cancer Research Fund. Nutrition and the Prevention of Cancer: A Global Perspective, Ed. World Cancer Res. Fund and American Institute for Cancer Res., Menasha: Banta Book Group, pp. 1-670, Washington, DC 1997.
120. Michels, K. B., Giovannucci, E., Joshipura, K. J., Rosner, B. A., Stampfer, M. I., Fuchs, C. S., Colditz, G. A., Speizer, F. E., and Willett, W. C. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J. Natl. Cancer Inst., 92: 1740-1752, 2000.
121. Harris, G. K., Gupta, A., Nines, R. G., Kresty, L. A., Habib, S. G., Frankel, W. L., Laperle, K., Gallaher, D. D., Schwartz, S. J., and Stoner, G. D. Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2′-deoxyguanosine levels in the Fischer 344 rat. Nutr. Cancer, 40: 125-133, 2001.
122. Morris, K. Combination rules in colorectal-cancer chemoprevention. Lancet Oncology, 1: 66, 2000.
123. Takayama, T., Katsuki, S., Takahashi, Y., Ohi, M., Nojiri, S., Sakamaki, S., Kato, J., Kogawa, K., Miyake, H., and Niitsu, Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N. Engl. J. Med., 339: 1277-1284, 1998.